GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Business Wire
Expands access to FDA-approved GLP-1 treatment with transparent pricing and integrated support through GoodRx for Weight LossBrief Summary:Wegovy® HD is now available on GoodRx at a self-pay price of $399 per monthPricing scales to $798 for two-month supply and $1,197 for three-month supplyAvailable at pharmacies nationwide through GoodRxConsumers can determine eligibility and obtain a prescription through GoodRx for Weight Loss SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that the new higher dose Wegovy® HD (semaglutide) injection 7.2 mg is now available to eligible self-pay patients on GoodRx at $399 per month. Pricing scales with quantity, with a two-month supply available for $798 and a three-month supply available for $1,197, giving consumers flexibility and clear expectations around cost. For patients, Wegovy HD offers an additional FDA-approved step-up option within the Wegovy portfo
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- Highly contagious stomach bug spreads fast, hitting certain patients hardest [FOX News]FOX News
- Letters to the Editor: When a few buyers control most medications, all consumers suffer [Los Angeles Times (CA)]Los Angeles Times
- GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference CallBusiness Wire
- 3 Reasons GDRX is Risky and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- GoodRx vs. CVS vs. Costco: Where Retirees Save the Most on Prescriptions [Yahoo! Finance]Yahoo! Finance
GDRX
Earnings
- 2/25/26 - Beat
GDRX
Sec Filings
- 4/15/26 - Form 4
- 4/15/26 - Form 4
- 4/3/26 - Form 8-K
- GDRX's page on the SEC website